EP3233108
Hraðverkandi insúlínsamsetningar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
9.12.2015EP published:
30.3.2022EP application number:
15817678.4
EP translation filed:
28.4.2022Grant published:
15.6.2022EPO information:
European Patent Register
Max expiry date:
8.12.2035Expiry date:
8.12.2026Next due date:
31.12.2026
Title in English:
RAPID-ACTING INSULIN COMPOSITIONSLanguage of the patent:
English
Timeline
Today
9.12.2015EP application
30.3.2022EP Publication
28.4.2022Translation submitted
15.6.2022Registration published
8.12.2026Expires
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, Indianapolis, IN 46285, US
Inventor
Name:
AKERS, Michael PatrickAddress:
Indianapolis, Indiana 46206-6288, US
Name:
MAJUMDAR, RanajoyAddress:
Indianapolis, Indiana 46206-6288, US
Name:
NGUYEN, Chi A.Address:
Indianapolis, Indiana 46206-6288, US
Name:
PAAVOLA, Chad D.Address:
Indianapolis, Indiana 46206-6288, US
Name:
SARIN, Virender KumarAddress:
Indianapolis, Indiana 46206-6288, US
Name:
SCHULTE, Nanette ElizabethAddress:
Indianapolis, Indiana 46206-6228, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201462092407 PDate:
16.12.2014Country:
US
Classification
Categories:
A61K 38/28, A61K 47/12, A61P 3/10
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 22.11.2022
Expires: 8.12.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 11.12.2023
Expires: 8.12.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 22.11.2024
Expires: 8.12.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 9.12.2025
Expires: 8.12.2026
Payer: Árnason Faktor ehf.